TY  - JOUR
AU  - Jiménez Galán, Rocío
AU  - Prado-Mel, Elena
AU  - Pérez-Moreno, María Antonia
AU  - Caballano-Infantes, Estefanía
AU  - Flores Moreno, Sandra
PY  - 2021
DO  - 10.3390/biology10090890
SN  - 2079-7737
UR  - https://hdl.handle.net/10668/27512
T2  - Biology
AB  - The KEYNOTE-024 clinical trial showed promising results for pembrolizumab in the first-line of treatment of advanced non-small-cell lung cancer (NSCLC). However, the profile of patients in real-world practice differs from those included in this...
LA  - en
KW  - Eastern Cooperative Oncology Group Performance Status (ECOG PS)
KW  - non-small-cell lung cancer
KW  - pembrolizumab
TI  - Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population.
TY  - research article
VL  - 10
ER  -